This was 1 year ago
LocationHerman Teirlinckgebouw (Vlaamse overheid)
After the success of the first edition in 2022, the Belgian National Contact Points (NCPs) are organising a second “Horizon Europe proposal workshop”.
The detailed agenda and modalities of the event are available here. In brief:
The target audience for this event are the less experienced researchers in proposal writing from Belgian companies, universities, research organisations, public institutes, etc. willing to participate to the programme Horizon Europe as beneficiary.
You can register here. Deadline for registration is 6 September. Registrations will be handled on a “first come, first served” basis. Participants to the former edition in 2022 of this workshop will be put on a waiting list giving priority to those who did not attend last year.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.